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Abstract--Soluble low Km 5'-nucleotidases have been purified from human cultured T- and B- 
lymphoblasts to compare their properties and to examine the mechanism of different rates of nucleotide 
dephosphorylation. The enzyme from B-lymphoblasts (MGL-8) was 4385-fold purified with a specific 
activity of 114 ~tmol/min/mg, while the enzyme from T-lymphoblasts (CEM, MOLT-4) was 4355-fold 
purified with a specific activity of 35 ~tmol/min/mg. The activity of both enzymes have an absolute 
requirement for Mg ÷÷. The B-cell enzyme has maximum activity with Mg 2÷ > Mn 2÷ > Co 2÷, while 
the T-cell enzyme had maximum activity with Co 2÷ > Mn 2÷ > Mg 2÷. The optimum activity was at 
pH 7.4-9.0 for the B-cell enzyme and pH 9.0 for the T-cell enzyme. Substrate specificity was the same 
for both enzymes with the following relative Vmax values: 
CMP > UMP > dUMP > dCMP > dAMP > IMP > GMP > dlMP > dGMP. 
The Km values for AMP and IMP were 12 and 25 IxM for the B-cell enzyme, and 7.0 and 12 ~tM for 
the T-cell enzyme. ATP and ADP are competitive inhibitors of these enzymes with apparent Ki values 
of 100 and 20 ~tM for the B-cell enzyme, and 44 ~tM and 8 pxM for the T-cell enzyme, respectively. 
The apparent molecular mass by gel filtration column chromatography is 145 kD for the B-ceU enzyme 
and 72 kDa for the T-cell enzyme. The subunit molecular masses by Western blots are 69.2 kD for 
both enzymes. 
These properties suggest that the B-lymphoblast enzyme is identical or similar to the enzyme from 
human placenta. However, the T-cell enzyme has some different properties. We conclude that these 
differences plus a lower content of low Km 5'-nucleotidase in T-cells may account for the decreased 
ability of T-lymphoblasts to dephosphorylate nucleotides and may contribute to the selective cyto- 
toxicity of deoxyribonucleosides for T-lymphoblasts as compared to B-lymphoblasts. 
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I N T R O D U C T I O N  
INTRACELLULAR nucleotide degradation in human 
cells is highly regulated [1-3]. A key step in this 
pathway is dephosphorylation of nucleotide 5 '-mono- 
phosphates catalyzed by 5'-nucleotidase (5'-ribo- 
nucleotide phosphohydrolase,  EC3.1.3.5) .  This 
enzyme is important  for intracellular nucleotide 
metabolism and adenosine release [4-6]. 
Abbreviations: BCIP, 5-bromo-4-chloro-3-indolyl phos- 
phate; NBT, nitro blue tetrazolium; MBS, m-maleimido- 
benzoyl-N-hydroxysuccinate ester; E-64, N-[N-(L-3-trans- 
carboxyoxiran-2-carbonyl)-L-leucyl]-agmatine; EG TA, 
ethyleneglycol-bis-(/3-aminoethyl ether) N,N,N 1,N 1- 
tetraacetic acid; PMSF, phenylmethylsulfonylflouride; 
SDS-PAGE, sodium dodecyl phosphate polyacrylamide 
gel electrophoresis. 
Correspondence to: Dr 3ozef Spychala, University of 
North Carolina, Department of Pharmacology, 
1106 FLOB, Chapel Hill, NC 27599-7365, U.S.A. 
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Available data indicate that 5'-nucleotidase from 
human T-lymphoblastoid cell lines has a low activity 
as compared to B-lymphoblastoid cell lines [7]. In T- 
lymphoblasts, intracellular nucleoside 5 '-monophos- 
phate dephosphorylation is lower compared with B- 
lymphoblasts or with T- and B-lymphocytes [5, 8-  
10]. Consequently,  under stress conditions, B-cells 
selectively release adenosine [11]. In addition, the 
activity of 5'-nucleotidase may have prognostic value 
in leukemias [12-15] and other diseases: it is 
decreased in the lymphocytes of immunodeficient 
patients with hypogammaglobulinemia [16-18] and 
patients with chronic lymphocytic leukemia [19], and 
in lymphoblasts of patients with acute T-cell lympho- 
blastic leukemia [12, 20]. Low intracellular 5'-nucleo- 
tidase activity may contribute to the accumulation of 
toxic deoxyribonucleoside triphosphates in immuno- 
deficient patients with adenosine deaminase deft- 
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ciency, or in the presence of adenosine deaminase 
inhibitors and with purine nucleoside phosphorylase 
deficiency [21-23]. 
The basis for the decreased dephosphorylat ing 
activity in human T-lymphoblasts  is unclear. The 
5 ' -phosphomonoes terase  activity is a composite  of 
nonspecific phosphatases  and specific 5'- 
nucleotidases. There  are two soluble specific 5'- 
nucleotidases in lymphoid tissue: low Km and high 
Km forms [24]. Our  previous studies determined that 
the decrease in 5 '-nucleotidase in T-lymphoblasts  is 
apparently related to the low Km form [24]. There-  
fore, as one approach to examine the decreased 
nucleoside 5 ' -monophospha te  activity of these cells, 
we have tested the hypothesis that there is an alter- 
ation of specific soluble low Km 5'-nucleotidase in T- 
lymphoblasts as compared  to B-lymphoblasts.  To 
accomplish this, we have adapted our purification 
and characterization of human placental and rat liver 
low K,, 5 '-nucleotidase [25, 26] to cultured B-lym- 
phoblast and T-lymphoblas t  soluble 5'-nucleotidases. 
E X P E R I M E N T A L  P R O C E D U R E  
Materials 
[8-14C]AMP (50mCi/mmol) and [8-14C]IMP (50mCi/ 
mmol) were purchased from Amersham Corporation (Chi- 
cago, IL). All nucleosides, 5'-monophosphates, ADP, 
ATP, adenosine, inosine, p-nitrophenylphosphate, gel fil- 
tration protein standards, imidazole, /3-mercaptoethanol, 
trizma base, ~r-methyl-D-mannoside, bovine serum 
albumin, goat anti-rabbit affinity purified IgG conjugated 
with alkaline phosphatase trypsin inhibitor (soybean), 1,10- 
phenanthroline, ol,/J-methylene adenosine diphosphate 
(AMPCP), ol,3-methylene adenosine triphosphate 
(AMPCPP), 3,~,-methylene adenosine triphosphate 
(AMPPCP), 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP) and nitro blue tetrazolium (NBT) were purchased 
from Sigma Chemical Co. (St Louis, MO). AMP- 
Sepharose 4B, Concanavalin A (Con A)-Sepharose., 
Sephacryl S-300, Sephadex G-25, blue dextran and columns 
were obtained from Pharmacia Fine Chemicals (Pisca- 
taway, N J). Bradford protein reagent, acrylamide, N,N'- 
methylene bisacrylamide, N,N,N',N'-tetramethylethyl- 
enediamine, ammonium persulfate, bromophenol blue, 
SDS-polyacrylamide gel protein standard kits of high and 
low molecular weight, biotinylated molecular weight stan- 
dards and streptavidin conjugated with alkaline phospha- 
tase, and the silver stain reagent kit were purchased from 
Bio Rad (Rockville Center, NY). The pressure ultrafiltr- 
ation unit with YM-10 membranes was obtained from 
Amicon (Danvers, MA). All other reagents used were of 
the highest quality generally available. 
Cell lines and cell culture 
Three human lymphoblastoid cell lines were used for 
our studies including T-lymphoblasts (CEM and MOLT- 
4) and B-lymphoblasts (MGL-8). The MGL-8 (B-lympho- 
blasts) cell line was derived from a normal individual and 
was a gift from the laboratory of Dr John Littlefield, Johns 
Hopkins University (Baltimore, MD). MOLT-4 and CEM 
(T-lymphoblasts) cell lines were obtained from HEM 
Research, Inc., Rockville, MD, and were originally derived 
from patients with acute lymphoblastic leukemia. All cell 
lines were grown in suspension culture using RPMI-1640 
media supplemented with 10% donor calf serum and 2 mM 
L-glutamine. The cells were maintained in logarithmic 
growth phase at 37°C and 5% CO2. Mycoplasma con- 
tamination was excluded by periodic microbiology tests. 
Enzyme assays 
Protein containing extracts of soluble 5'-nucleotidase 
were incubated for 30 min or 60 min at 37°C in a reaction 
mixture containing 62.5 mM imidazole-HC1 pH 7.4, 20 mM 
MgC12, 1 mg/ml bovine serum albumin, and 0.2 mM [8- 
14C]AMP or [8-14C]IMP in a total volume of 100 ~tl. After 
stopping the reaction by heating at 85°C for 2 min, pre- 
cipitated protein was removed by centrifugation. Twenty 
microliters were spotted on Whatman 3MM chroma- 
tography paper with 20 ~tl nonradioactive nucleosides and 
nucleotides (1 mg/ml). Nucleosides and nucleotides were 
separated by high voltage electrophoresis at 4000 V and 
250 mA for 30 min in 50 mM sodium borate pH 9. Nucleo- 
side and nucleotide spots were located with an ultraviolet 
light, cut out and counted in LKB Rackbeta liquid scin- 
tillation spectrometer. In addition, enzyme activity was 
measured by release of inorganic phosphate (Pi) in incu- 
bation media of 200 p~l containing 67 mM imidazole-HCl 
pH 7.4, 20 mM MgCI2, 1 mg/ml bovine serum albumin and 
5 mM AMP. The reaction was stopped by the addition of 
50 Ixl of 10% trichloroacetic acid. The amount of Pi lib- 
erated was determined by the method of Chen et al. [27]. 
Non-specific phosphatase activity was measured in an 
incubation mixture containing 62.5 mM imidazole pH 7.4, 
20mM MgCI2, l mg/ml bovine serum albumin and 
12.5 mM p-nitrophenylphosphate. The reaction was incu- 
bated for 30 min at 37°C and stopped with the addition 
of 0.8 ml 0.4M NaOH. The samples were clarified by 
centrifugation and the optical density measured at 400 nm 
on a Gilford 260 spectrophotometer. 
Protein assay 
Protein concentration was estimated by the method of 
Bradford [28] with alcohol dehydrogenase as the standard. 
Proteins eluting from the columns during the various puri- 
fication steps were monitored by absorbance at 280 nm or 
by the Bradford method. 
Preparation of cell extracts 
Cells were collected by centrifugation, washed three 
times, and resuspended in 0.25 M sucrose, 1 mM MgCI2, 
and 10 mM Tris-HCl pH 7.4. The cell pellet was stored at 
-70°C. The frozen cells were thawed, suspended in 20 mM 
imidazole-HCl, pH 7.0, 20 mM MgCI2 (buffer A) to 5 × 10 ~ 
cells/ml, and were lysed by nitrogen bomb cavitation 
(1000lb./in. 2 for 30min at 4°C) and by Dounce tissue 
homogenizer (about 30-40 strokes). The lysate was spun 
for 10 min at 10,000 × g to remove cellular debris. The 
supernatant was spun at 50,000 × g for 2 h to eliminate 
the remaining cellular membranes and then was dialyzed 
overnight at 4°C against 10 mM Tris-HCl pH 7.4, and 
20 mM MgCI 2. This lymphoblast supernatant was then used 
immediately for enzyme purification. 
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Enzyme purification 
The purification used was similar to our procedure for 
human placental soluble 5'-nucleotidase [25]. The lym- 
phoblast supernatant (50 ml) was passed through an AMP- 
Sepharose 4B affinity chromatography column. Soluble 5'- 
nucleotidase activity was eluted from the column with 60 ml 
of 10 mM ADP in 20 mM imidazole-HC1 pH 7.0 and 20 mM 
MgCI2 (buffer A). The eluate was concentrated from 25 ml 
to 2 ml using an AMICON pressure ultrafiltration unit with 
YM-10 membrane. 
Concentrate (2 ml) from the AMP-Sepharose column 
was then applied to a Sephacryl S-300 gel filtration column 
equilibrated with buffer A. The fractions with the highest 
activity were pooled (17 ml) and applied to concanavalin 
A-Sepharose 4B column. This column was then washed 
with 45 ml of 20 mM imidazole-HC1 pH 7.0 and 20 mM 
MgCI2. The enzyme was eluted in a single peak with 45 ml 
of 0.5 M o~-methylmannoside at 37°C in buffer A. The 
eluate from the concanavalin A-Sepharose was immedi- 
ately concentrated to 1.5 ml to preserve enzyme stability. 
This preparation was stored at 4°C and used for our charac- 
terization studies. 
Modifications of the purification were made to obtain 
proteins for subunit molecular weight determinations by 
Western blot. The T- and B-lymphoblast extract was 
applied to 20ml concanavalin A-Sepharose columns 
according to the procedure described for rat liver 5'-nucleo- 
tidase purification [26]. The pooled, concentrated and dia- 
lyzed active fractions were passed through a DE-52 ion 
exchange column. The preparations after DE-52 chroma- 
tography were taken for Western blot analysis. 
Molecular weight determination 
The molecular weight of the native purified proteins 
were determined by gel filtration chromatography on a 
Sephacryl S-300 column (1.6 × 70cm) equilibrated with 
5% glycerol, 20 mM MgCIz, 60 mM imidazole-HC1 pH 7.0, 
and 0.02% sodium azide. Two milliliter samples were 
applied, the column flow rate was 6 ml/h, and 1.75 ml 
fractions were collected. We used blue dextran and di- 
n~trophenylalanine to determine the void volume and 
exclusion volume, respectively. The void volume was 55 ml 
and the excluded volume was 150ml. The column was 
standardized with aldolase (Mr = 140,000), bovine serum 
albumin (Mr = 67,000), ovalbumin (Mr = 43,000), alpha- 
chymotrypsinogen A (Mr = 25,000), and cytochrome C 
(Mr = 12,000). The protein was estimated by absorbance 
at 280 nm. Kay was calculated for each standard according 
to the method of Laurent and Kilander [29] and Siegel and 
Monty [30]. The molecular weights and Stokes radius were 
determined from the plot of Kay vs the molecular weight 
and Stokes radius of the standard proteins. 
Subunit molecular weight determination 
Western blot procedure was used to determine the mol- 
ecular weights of T- and B-lymphoblast 5'-nucleotidase. 
Rabbit antibodies raised against a peptide derived from 
human placental soluble low Km 5'-nucleotidase were used 
to bind to the enzyme protein immobilized on nitro- 
cellulose. A peptide for amino acid sequence analysis was 
prepared by trypsin digestion of pure 5'-nucleotidase puri- 
fied to 800 ~tmol/min/mg protein specific activity. The 
sequence analysis yielded a 17 amino acid sequence. The 
synthetic peptide with attached cysteine at the N-terminus 
was conjugated with keyhole limpet hemocyanin (KLH, 
50:50w/w). One milligram of conjugate with complete 
Freund's adjuvant (1 ml of total volume) was injected 
subcutaneously to the rabbit at 13 different spots. One- 
half milligram of peptide-KLH conjugate and incomplete 
Freund's adjuvant were injected every 4 weeks and the 
blood was drawn 10 days after each injectio n. 
Polyacrylamide slab gel electrophoresis with human pla- 
centa, B-and T-lymphoblast soluble low Km 5'-nucleotidase 
and biotynylated standards was run with sodium dode- 
cylsulfate according to standard procedure [31] and the gel 
was electroblotted with Bio-Rad Trans-blot cell at 60 V for 
6h. The nitrocellulose was blocked with 5% dry milk 
overnight and incubated with 1:1000 rabbit serum for 3 h. 
The bands were developed with goat anti-rabbit alkaline 
phosphatase conjugated antibodies. Biotinylated standards 
with avidin conjugated with alkaline phosphatase were 
used to determine molecular weight. Color reaction was 
developed with BCIP and NBT as described [32]. The 
molecular weight of the enzymes was determined by meas- 
uring R/values and comparing them to the Rf values of 
known biotinylated protein standards (Bio-Rad): phos- 
phorylase B (97.4 kD), bovine serum albumin (66.2 kD), 
ovalbumin (42.7kD), carbonic anhydrase (31.0kD) 
soybean trypsin inhibitor (21.5 kD), and lysozyme 
(14.4 kD). 
Kinetics and calculations 
The Km values were determined from initial velocity 
studies. For each study there were at least six different 
substrate concentrations. Each determination was carried 
out 2-4 times in duplicate. Double reciprocal plots of 
initial velocity vs the substrate concentration were used to 
estimate the Km values. Linearity with time was established 
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FIG. 1. 5'-AMP-Sepharose 4B affinity chromatography. 
Forty milliliters of either T- or B-lymphoblast supernatants 
(shown for B-lymphoblasts only) were applied to 20 ml 
5'-AMP-Sepharose 4B affinity columns (2.5 × 7 cm). The 
column was equilibrated with buffer A (see Experimental 
Procedure). After application of the enzyme extract, the 
column was washed with 120ml buffer A to remove 
unbound proteins and then was washed with 60 ml 0.5 M 
NaC1 in buffer A to remove non-specifically bound 
proteins. Subsequently, the bound soluble 5'-nucleotidase 
was eluted with about 90 ml of 10 mM ADP in buffer A. 
The active fractions were pooled, concentrated using an 
Amicon YM-10 filter. 
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TABLE 1. PURIFICATION OF SOLUBLE LOW g m 5'-NUCLEOT1DASE FROM B-LYMPHOBLASTS (MGL-8)  
Total Specific Total 
protein activity enzyme Purification Recovery 
Step (mg) (~tmol/min/mg) 0xmol/min) (fold) (%) 
Lymphoblast supernatant 351 
AMP Sepharose-4B 7.62 
AMP-Sepharose concentrate 5.18 
Sephacryl S-300 0.15 
Con A-Sepharose concentrate 0.04 
0.026 8.3 - -  100 
0.840 6.4 32 76 
0.820 4.3 32 51 
33.36 4.2 1283 50 
114.0 4.0 4385 48 
TABLE 2. PURIFICATION OF SOLUBLE LOW K m 5'-NUCLEOTIDASE FROM T-LYMPHOBLASTS (MOLT-4) 
Step 
Total Specific Total 
protein activity enzyme Purification Recovery 
(mg) (ixmol/min/mg) (p, mol/min) (fold) (%) 
Lymphoblasts supernatant 637 
AMP Sepharose-4B 20.5 
AMP-Sepharose concentrate 20.0 
Sephacryl S-300 0.10 
Con A-Sepharose concentrate 0.05 
0.008 5.1 - -  100 
0.212 4.4 27 87 
0.220 4.3 30 83 
17.4 1.8 2176 36 
34.7 1.7 4335 34 
for different concentrations used in initial velocity studies 
for K,, determinations. Lineweaver-Burk plots of initial 
velocity vs concentration of substrate were linear. Kinetic 
data were fitted to the simple Michaelis-Menten equation, 
i.e. a hyperbola, by a modification of Cleland's program 
(Cleland, 1967), on a Vax 11/730 minicomputer. 
RESULTS 
Purification 
Both enzymes showed a similar purification profile 
(Fig. 1). The initial step of purification with AMP- 
Sepharose affinity chromatography removes all non- 
specific phosphatase activity from the crude prep- 
aration, since these enzymes pass through the 
column. This step shows consistent elution of a single 
peak of 5'-nucleotidase activity. The enzyme activity 
peak elutes from the gel filtration column in a same 
major protein peak (data not shown) separated from 
other proteins. 
The purification of soluble 5'-nucleotidase from B- 
lymphoblasts yielded a 4385-fold purified enzyme 
with a specific activity of 114 ~tmoles/min/mg protein 
(Table 1). The final recovery was 48%. Gel filtration 
column chromatography yielded a 40-fold puri- 
fication with a recovery of 68%. Con-A-Sepharose 
affinity chromatography yielded a 3.5-fold puri- 
fication with a consistent 96% recovery. 
The purification of cytoplasmic 5'-nucleotidase 
from T-lymphoblasts (MOLT-4) yielded 4335-fold 
purified enzyme with a specific activity of 40 Ixmol/ 
min/mg, and final recovery of 34% (Table 2). In this 
case the gel filtration column also yielded a 72-fold 
purification, with a 43% recovery. Concanavalin A- 
TABLE 3. EFFECT OF DIVALENT CATIONS ON CYTOPLASMIC 
LOW g m 5'-NUCLEOTIDASE ACTIVITY FROM T-AND B- 
LYMPHOBLASTS 
Enzyme (% of control) 
activity* 
T-lymphoblasts 
Divalent cation B-lymphoblasts 
(7.5 mM) (MGL-8) (CEM) (MOLT-4) 
Mg 100 100 100 
Mn 79 107 115 
Co 78 142 132 
Ba 74 23 28 
Ca 72 12 7 
Cu 57 60 57 
Ni 55 53 47 
Zn 34 56 53 
Fe 33 15 14 
* The activity is expressed as the percent of the value 
with Mg which have the following in Ixmol/min/mg: MGL- 
8, 110; CEM, 37: MOLT-4, 35. 
Sepharose chromatography yielded a 2.0-fold puri- 
fication with a 90% recovery. The enzyme purified 
from CEM T-lymphoblasts had identical properties. 
Divalent cations 
The enzyme was dialyzed against 10 mM Tris-HC1 
pH7.4  and 0 .2mM EDTA and was assayed with 
different divalent cations at 7.5 mM (Table 3). There 
was no activity of these enzymes without Mg +÷. As 
compared to Mg ++, the B-lymphoblast enzyme was 
79% effective with Mn and was 78% effective with 
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TABLE 4. ACTIVITY OF CYTOPLASMIC LOW g m 5P-NUCLEO - 
TIDASE FROM T- AND B-LYMPHOBLASTS WITH VARIOUS 
SUBSTRATES 
Enzyme activity (% of control) 
B-lymphoblasts T-lymphoblasts 
Substrate (MGL-8) (CEM) (MOLT-4) 
(2.5 mM) (p.mol/min/mg) (~tmol/min/mg) 
CMP 240.8 (247)* 25.3 (248) 14.7 (233) 
UMP 237.4 (244) 24.1 (236) 13.3 (211) 
dUMP 209.0 (215) 13.7 (135) 7.3 (116) 
dCMP 203.0 (208) 16.3 (160) 7.8 (124) 
dAMP 101.0 (104) 12.3 (119) 6.4 (102) 
AMP 97.4 (100) 10.2 (100) 6.3 (100) 
IMP 95.0 (98) 8.9 (87) 4.4 (70) 
GMP 91.0 (93) 8.3 (81) 4.2 (67) 
dIMP 66.0 (68) 8.0 (78) 3.1 (49) 
dGMP 46.0 (47) 6.6 (65) 6.9 (110) 
TMP - -  4.9 (48) 3.0 (48) 
FIG. 2. pH activity profile of T- and B-lymphoblasts soluble 
low Km 5'-nucleotidases. The enzymes were assayed under 
standard conditions at different pH values using 100 ~tM 
AMP as substrate. The B-lymphoblast enzyme has an 
optimum pH plateau from pH 7.4 to 9.0, while both T- 
lymphoblast enzymes have a pH optimum of 9.0. 
Co ++. In contrast,  the T-cell enzyme showed a 
greater preference for cobalt (132-142%) and 
manganese (107-115 %). The B-lymphoblast enzyme 
had substantially more activity than the T-lym- 
phoblast enzyme with the addition of Ba, Ca or Fe. 
Both enzymes displayed an activation curve with 
magnesium, reaching its maximum activity between 
10 and 20 mM MgCIz-. No AMP dephosphorylation 
occurred without magnesium. 
* The values in brackets are percentages calculated using 
the activity with AMP as 100%. 
blasts had maximum activity at pH 7.4 and remained 
at a plateau up to pH 9.0 (Fig. 2). In contrast,  the 
T-lymphoblast enzyme with the same experimental  
conditions has its maximum activity peak at pH 9.0. 
Substrate specificity 
When soluble 5'-nucleotidases from T- and B- 
lymphoblasts were assayed with different nucleoside 
5 '-monophosphates at the same concentration of 
2.5 mM, the enzymes showed high activity with CMP, 
UMP, dCMP and dUMP (Table 4). There  is no 
difference in the substrate preference.  
pH optimum 
Soluble 5'-nucleotidase purified from B-lympho- 
Kinetic properties 
Initial velocity studies were performed with dif- 
TABLE 5. KINETIC VARIABLES FOR CYTOPLASMIC LOW g m 5CNUCLEOTIDASES FROM T- AND 
B-LYMPHOBLASTS 
B-lymphoblast T-lymphoblast 






Km (~tM) Ki app (~tM) K,, (,M) Ki app (~tM) 
12 - -  7.0 - -  
25 - -  10 - -  
- -  2 0  - -  8.0 
- -  1 1 0  - -  55 
- -  23,000 - -  16,000 
% inhibition 
AMPCP (100 ~tM) 70 73 
AMPCPP (100 ixM) 10 25 
AMPPCP (100 ixM) 10 12 
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FIG. 3. Molecular weight and Stokes radii of T- and B- 
lymphoblast soluble low K,. 5'-nucleotidases on Sephacryl 
S-300. A Sephacryl S-300 gel filtration column was cali- 
brated as described in Experimental Procedure, using cyto- 
chrome C (12.4kD), alpha-chymotrypsinogen (25kD), 
ovalbumin (43 kD), bovine serum albumin (67 kD), and 
aldolase (140 kD). The apparent molecular mass of the B- 
iymphoblast enzyme is 145 kD as compared to the T- 
lymphoblast enzyme of 72.5 kD (panel A). The Stokes 
radius of the B-lymphoblast enzyme is 47.4 A, while the 
T-lymphoblast enzyme is 37.0 (panel B). 
ferent concentrations of AMP or IMP. Soluble 5'- 
nucleotidases purified from T- and B-lymphoblasts 
displayed hyperbolic kinetics. Double reciprocal 
plots of initial velocity studies are linear. The K,, 
values for the B-lymphoblast enzyme are 12 IxM for 
AMP and 25 IxM for IMP. The T-lymphoblast 
enzyme showed Km values of 7 I~M and 12 txM for 
AMP and IMP, respectively (Table 5). 
Inhibition studies of soluble 5'-nucleotidases were 
performed at different concentrations of AMP and 
fixed concentrations of ATP (100 IxM), ADP (25 IxM) 
and Pi (25 mM). With double reciprocal plots of 
initial velocity data, ATP or ADP produce changes in 
the slope only consistent with competitive inhibition. 
The apparent Ki values were 100 and 20 I~M for 
ATP and ADP, respectively, for the B-lymphoblast 
enzyme. The apparent Ki values were 55 IxM for ATP 
and 8 IIM for ADP for the T-lymphoblast enzyme. 
Inhibition studies with Pi show changes in both the 
slope and intercept, suggesting non-competitive inhi- 
bition. The apparent Ki values were 23 mM (slope), 
and 44 mM (intercept) for the B-cell enzyme, and 
16 mM (slope) and 38 mM (intercept) for the T-cell 
enzyme (Table 5). 
Molecular weight determination 
The native molecular weights of T- and B-lym- 
phoblast cytoplasmic 5'-nucleotidases were esti- 
mated from the elution of the known molecular 
weight standards from the Sephacryl S-300 gel fil- 
tration column. The elution volume of B-lymphoblast 
soluble 5'-nucleotidase indicates a molecular mass of 
145 kD with a Stokes radius of 47.4/~ (Figs 3 and 4). 
The enzyme from T-lymphoblasts was found to have 
a molecular mass of 72.5 kD with a Stokes radius of 
37.0/~ (Figs 3 and 4). 
Subunit molecular weight 
The Western blot analysis yielded a molecular 
mass of 69.2 kD for B- and T-lymphoblast 5'-nucleo- 
tidases. This compares with 70.6 kD by the same 
procedure for human placental enzyme (Fig. 5). 
DISCUSSION 
Cultured human T- and B-lymphoblasts provide a 
model system for critical examination of the relation- 
ships between nucleotide degradation and 5'-nucleo- 
tidase activities. T-lymphoblasts have a decreased 
ability to dephosphorylate intracellular nucleotides 
as compared to B-lymphoblasts [5,8,10]. In 
addition, T-lymphoblasts have a lower activity of 
soluble and membrane bound 5'-nucleotidases (low 
K,, type) relative to B-lymphoblasts [5, 7-10, 24, 34]. 
The discovery of leukemias and immunodeficiency 
states with absent or low levels of 5'-nucleotidase 
activity has created further interest in its metabolic 
significance [12, 16-21, 23]. 
Our observations have elucidated a number of 
distinguishing properties between soluble low K,, 5'- 
nucleotidase from T- and B-lymphoblasts on the one 
hand and between lymphoblast and human placental 
enzyme on the other. 
Firstly, there is a substantial difference in the 
AMP-dephosphorylating activity between these 
cells. The B-cell enzyme is several times more active 
than the T-cell enzyme in crude extracts as previously 
described [5, 10, 20]. Furthermore, the pH activity 
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FIG. 4. 5'-AMP-Sepharose 4B affinity chromatography. 
Eluates from concanavalin A-Sepharose were applied to a 
second AMP-Sepharose 4B chromatography column. The 
columns were washed with 30 ml of buffer A and the 
enzymes were eluted with 15 ml of 10 mM CMP in buffer 
A. Panel A shows the profile for B-cell enzyme (MGL-8), 
while panel B the profile for T-cell enzyme (MOLT-4). 
profiles are different for soluble 5'-nucleotidase iso- 
lated from T- and B-lymphoblasts. The T-lym- 
phoblast enzyme pH activity peak most closely 
resembles alkaline phosphatase [35]. In contrast, the 
B-lymphoblast 5'-nucleotidase is similar to the soluble 
5'-nucleotidase from human placenta and bovine liver 
which have a plateau of activity from pH 7.4 to 9.0 
[36]. This is different from the crude soluble prep- 
arations of T- and B-lymphoblasts and the high Km 
enzyme partially purified from lymphoblasts, human 
malignant lymphocytes, and rat and chicken liver, 
which have pH optima from 6.3 to 6.5 [5, 8,9,  
37-40]. 
Several catalytic properties of the B-lymphoblast 
enzyme are similar to the human soluble placental 
5'-nucleotidase [25]. They have similar Km values for 
AMP and IMP, similar K i values for ATP, ADP 
and inorganic phosphate. Our results contrast with 
previously observed Km values of 330 ~tM for AMP 
with crude soluble preparation of B-cells, and Km 
values of 620 txM or higher for AMP with partially 
purified from lymphoid cells [8, 9]. The latter obser- 
vation relates to the high Km 5'-nucleotidases. Cyto- 
plasmic high K,, 5'-nucleotidases from other sources 
have Km values for AMP and IMP, which are one or 
two orders of magnitude higher [8, 9, 38-42]. 
Although both low Km 5'-nucleotidases have an 
absolute requirement for magnesium, divalent cation 
preference distinguishes T- and B-lymphoblast low 
Km 5'-nucleotidases. B-lymphoblast 5'-nucleotidase 
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A B C  
FIG. 5. Western blot of soluble low Km 5'-nucleotidase 
from human B-lymphoblasts (A), T-lymphoblasts (B) and 
placenta (C). A 7.5% gel was electroblotted onto nitro- 
cellulose, reacted with rabbit anti-peptide monospecific 
antibodies and visualized with alkaline phosphatase-con- 
jugated goat anti-rabbit IgG and BCIP and NBT staining 
[32]. Pure soluble low Km 5'-nucleotidase from human 
placenta was included for comparison. 
has the highest activity with magnesium as has been 
observed with other soluble 5'-nucleotidases and 
membrane 5'-nucleotidases [9, 25, 37-40]. In 
contrast, the T-cell enzyme has maximum activity 
with cobalt and manganese. In addition, the enzymes 
are different by virtue of their preference for Ca, Ba 
or Fe. 
The substantial differences in catalytic properties 
of T- and B-lymphoblast enzymes was supported by 
a major alteration in molecular weight. Soluble 5'- 
nucleotidase isolated from B-cells is similar to a num- 
ber of mammalian enzymes with low Km 5'-nucleo- 
tidase activity [25, 26, 44]. The native protein is a 
dimer of  145 kD of molecular mass and 69.2 kD for 
each subunit. On the other hand, the enzyme from 
T-cells appears to be a monomer with molecular mass 
of 69.2-72.5 kD. Structural differences related to 
carbohydrate moiety have been already shown for 
structurally related plasma membrane 5'-nucleo- 
tidase [45]. Whether this is the case for these two 
enzymes and whether the altered catalytic properties 
of the enzyme from T-cells are related to the inability 
to form a dimeric structure remains to be established. 
In an attempt to investigate if there is another and/or 
different species of mRNA coding for low Km 5'- 
nucleotidase in T-cells we have performed a Northern 
blot analysis. We have been unable to detect any 
level of mRNA for low Km 5'-nucleotidase in B- 
and T-cells with up to 30 ~tg total RNA and human 
placenta low Km cDNA as a probe (data not shown). 
There are some important biological implications 
of the reduced and altered low Km 5'-nucleotidase 
activity in T-lymphoblasts. Firstly, if the low K,, 
soluble 5'-nucleotidase particles in intracellular 
nucleotide degradation, it seems possible that the 
altered properties of the enzyme may explain the 
decreased dephosphorylating activity of these cells. 
Secondly, the preference of soluble low Km 5'-nucleo- 
tidase for deoxycytidine 5'-monophosphate may 
facilitate the generation of deoxycytidine. This may 
explain the selective toxicity of deoxyadenosine for 
T-lymphoblasts as compared to B-lymphoblasts [7- 
9, 34, 46]. The soluble low Km 5'-nucleotidase in B- 
lymphoblasts may generate levels of deoxycytidine 
sufficient to saturate deoxycytidine kinase and inhibit 
deoxyadenosine and deoxyguanosine phosphoryl- 
ation [47, 48]. In T-lymphoblasts, the reduced and 
kinetically altered activity of soluble low Km 5'- 
nucleotidase and the resultant decreased ability for 
the removal of excess of nucleoside monophosphates 
optimizes the conditions for the preferential phos- 
phorylation of accumulated deoxyadenosine and 
deoxyguanosine to toxic deoxynucleoside triphos- 
phates. Similar metabolic conditions may contribute 
to the selective cytotoxicity of deoxyribonucleosides 
for T-cells in immunodeficient patients with adeno- 
sine deaminase deficiency or purine nucleoside phos- 
phorylase deficiency [21,23] or to the selective 
adenosine release from B cells [11]. 
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